Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 159 Enz. Inhib. hit(s) with all data for entry = 7938
TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225138(US9328118, 39)
Affinity DataIC50:  0.610nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225125(US9328118, 26)
Affinity DataIC50:  0.610nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225225(US9328118, 158)
Affinity DataIC50:  0.620nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225209(US9328118, 141)
Affinity DataIC50:  0.650nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225128(US9328118, 29)
Affinity DataIC50:  0.660nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225109(US9328118, 6)
Affinity DataIC50:  0.690nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225119(US9328118, 19)
Affinity DataIC50:  0.700nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225156(US9328118, 72)
Affinity DataIC50:  0.730nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225123(US9328118, 24)
Affinity DataIC50:  0.760nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225154(US9328118, 70)
Affinity DataIC50:  0.760nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225123(US9328118, 24)
Affinity DataIC50:  0.800nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225127(US9328118, 28)
Affinity DataIC50:  0.810nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225139(US9328118, 40)
Affinity DataIC50:  0.850nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225202(US9328118, 122)
Affinity DataIC50:  0.870nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225203(US9328118, 135)
Affinity DataIC50:  0.890nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225190(US9328118, 110)
Affinity DataIC50:  0.910nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225185(US9328118, 105)
Affinity DataIC50:  0.910nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225148(US9328118, 54)
Affinity DataIC50:  0.940nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225129(US9328118, 30)
Affinity DataIC50:  0.970nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225205(US9328118, 137)
Affinity DataIC50:  1nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225200(US9328118, 120)
Affinity DataIC50:  1nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225107(US9328118, 3)
Affinity DataIC50:  1nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225121(US9328118, 21)
Affinity DataIC50:  1nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225138(US9328118, 39)
Affinity DataIC50:  1nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225213(US9328118, 145)
Affinity DataIC50:  1nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225140(US9328118, 41)
Affinity DataIC50:  1.10nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225125(US9328118, 26)
Affinity DataIC50:  1.20nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225106(US9328118, 2)
Affinity DataIC50:  1.20nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225126(US9328118, 27)
Affinity DataIC50:  1.30nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225168(US9328118, 84)
Affinity DataIC50:  1.30nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225155(US9328118, 71)
Affinity DataIC50:  1.30nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225127(US9328118, 28)
Affinity DataIC50:  1.40nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225163(US9328118, 79)
Affinity DataIC50:  1.40nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225222(US9328118, 155)
Affinity DataIC50:  1.5nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225211(US9328118, 143)
Affinity DataIC50:  1.5nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225210(US9328118, 142)
Affinity DataIC50:  1.5nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225161(US9328118, 77)
Affinity DataIC50:  1.5nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225204(US9328118, 136)
Affinity DataIC50:  1.5nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225124(US9328118, 25)
Affinity DataIC50:  1.60nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225220(US9328118, 153)
Affinity DataIC50:  1.60nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225111(US9328118, 8)
Affinity DataIC50:  1.60nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225156(US9328118, 72)
Affinity DataIC50:  1.60nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225202(US9328118, 122)
Affinity DataIC50:  1.70nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225218(US9328118, 150)
Affinity DataIC50:  1.70nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225133(US9328118, 34)
Affinity DataIC50:  1.70nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225119(US9328118, 19)
Affinity DataIC50:  1.70nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225196(US9328118, 116)
Affinity DataIC50:  1.80nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Mouse)
Astellas Pharma

US Patent
LigandPNGBDBM225147(US9328118, 52)
Affinity DataIC50:  1.80nMAssay Description:First, spleen cells collected from C57BL/6 mice were seeded in a 96-well plate so as to be a 1× 105 cells/well, then, 5-fold dilution of 10 mM DMSO s...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225193(US9328118, 113)
Affinity DataIC50:  1.90nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetCathepsin S(Human)
Astellas Pharma

US Patent
LigandPNGBDBM225169(US9328118, 86)
Affinity DataIC50:  1.90nMAssay Description:5 μL of a human cathepsin S enzyme (R&D1183-CY-010) was added to a 96-well plate so as to be 20 ng/well. Next, 10-fold dilution of the test comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


Displayed 1 to 50 (of 159 total ) | Next | Last >>
Jump to: